Last update 22 May 2025

YHR-1703/YHR-1704

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Amlodipine/rosuvastatin, Rosuampin, YH-1701
+ [2]
Target-
Action-
Mechanism-
Therapeutic Areas
Cardiovascular DiseasesEndocrinology and Metabolic Disease
Active Indication-
Inactive Indication
HyperlipidemiasHypertension
Originator Organization
Yuhan Corp.
Active Organization-
Inactive Organization
Yuhan Corp.
License Organization-
Drug Highest PhasePendingPhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with YHR-1703/YHR-1704
NCT03951207
/ CompletedPhase 4
Randomized, Multicenter, Parallel, Open, Phase 4 Study to Compare the Efficacy and Safety of Rosuvastatin/Amlodipine Combination Therapy Versus Atorvastatin/Amlodipine Combination Therapy in Hypertension Patient With Dyslipidemia
NCT03103256
/ CompletedPhase 3
A Multi-center, Randomized, Double-blind, Parallel-group Phase III Clinical Trial to Evaluate the Efficacy and Safety of YHP1701 Fixed Dose Combination in Patients With Dyslipidemia and Hypertension
NCT03088254
/ CompletedPhase 3
A Multi-center, Randomized, Double-blind, Parellel Phase III Clinical Trial to Evaluate the Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin in Patients With Dyslipidemia and Hypertension
100 Clinical Results associated with YHR-1703/YHR-1704
Login to view more data
100 Translational Medicine associated with YHR-1703/YHR-1704
Login to view more data
100 Patents (Medical) associated with YHR-1703/YHR-1704
Login to view more data
100 Deals associated with YHR-1703/YHR-1704
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HyperlipidemiasPhase 3
United States
Yuhan Corp.
17 May 2017
HypertensionPhase 3
United States
Yuhan Corp.
17 May 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free